𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Activity of human monocytes in IgE antibody-dependent surveillance and killing of ovarian tumor cells

✍ Scribed by Sophia N. Karagiannis; Qin Wang; Nick East; Frances Burke; Stephane Riffard; Marguerite G. Bracher; Richard G. Thompson; Stephen R. Durham; Lawrence B. Schwartz; Frances R. Balkwill; Hannah J. Gould


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
412 KB
Volume
33
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

We have previously shown that a chimeric IgE antibody against the folic acid receptor (MOv18 IgE) inhibits tumor growth in a SCID mouse model of ovarian carcinoma. MOv18 IgE gave greater protection than the corresponding chimeric MOv18 IgG1. We have now confirmed these effects in a nude‐mouse model of ovarian carcinoma and have demonstrated for the first time that human monocytes are active in IgE antibody‐dependent cell‐mediated cytotoxicity. Injection of tumor‐bearing mice with PBMC and MOv18 IgE led to infiltration of monocytes into the tumors and prolonged survival of the mice.Incubation of PBMC or purified monocytes and MOv18 IgE with ovarian tumor cells in vitro resulted in tumor cell killing proportional to the expression of unoccupied FcϵRI on monocytes.We observed phagocytosis of tumor cells by the monocytes in vitro. Our results suggest that tumor‐specific IgE antibodies may be exploited for immunotherapy of cancer.


📜 SIMILAR VOLUMES


Sensitization by interleukin-lα of carbo
✍ Zheng Wang; Kang Bo Lee; Eddie Reed; Biranda K. Sinha 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 513 KB

Cytokines are directly cytotoxic to tumor cells in vitro and in vivo, and interleukinla (ILla) potentiates the cytotoxicity of a number of clinically active drugs in several human tumor cells, including carcinomas of the breast and ovary. In this study, we found that ILla potentiated the cytotoxicit

The antitumor activity of an anti-CD54 a
✍ Kimberly J. Brooks; Elaine J. Coleman; Ellen S. Vitetta 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 293 KB

## Abstract We have previously described the development and testing of a monoclonal anti‐human CD54 antibody (UV3) in SCID mice xenografted with human multiple myeloma, lymphoma, and melanoma cell lines. In all 3 cases, UV3 was highly effective at slowing the growth of tumors and/or prolonging sur

Transforming growth factor-β1-dependent
✍ Kiyoshi Wakahara; Hiroshi Kobayashi; Tatsuo Yagyu; Hidenori Matsuzaki; Toshiharu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 617 KB

## Abstract The net balance between urokinase‐type plasminogen activator (uPA) and plasminogen activator inhibitor type‐1 (PAI‐1) has been implicated in tumor cell invasion and metastasis. To elucidate the mechanism of the transforming growth factor‐β1 (TGF‐β1)‐dependent up‐regulation of PAI‐1 expr